Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/12/2010US20100204195 Pharmaceutical Compositions and Process for Making Them
08/12/2010US20100204194 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
08/12/2010US20100204193 Metal complexes incorporated within biodegradable nanoparticles and their use
08/12/2010US20100204192 Agents, compositions and methods for enhancing neurological function
08/12/2010US20100204191 Function-Selective Vitamin D Receptor Agonist
08/12/2010US20100204190 New combinations
08/12/2010US20100204189 Methods and Compounds for Vitamin D Therapy
08/12/2010US20100204188 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
08/12/2010US20100204187 Purine Derivatives
08/12/2010US20100204186 Aromatic a-ring derivatives of tetracycline compounds
08/12/2010US20100204185 Phenazopyridine compounds
08/12/2010US20100204184 Phosphonates useful as modulators of T-gamma-9-delta-2 activity
08/12/2010US20100204183 Substituted Phosphonates and Their Use In Decreasing Amyloid Aggregates
08/12/2010US20100204182 Ectonucleotidase inhibitors
08/12/2010US20100204181 N-halogenated amino acid formulations comprising phosphine or amine oxides
08/12/2010US20100204180 Proteasome inhibitors
08/12/2010US20100204178 Novel parenteral carbamazepine formulation
08/12/2010US20100204177 Process for preparing thermosensitive (poly(ethylene oxide) poly(propylene oxide)) derivates that can be used to functionalize chitosan
08/12/2010US20100204176 Advanced glycation end products as active ingredients
08/12/2010US20100204175 Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases
08/12/2010US20100204174 Novel active ingredient in cicatrization and use thereof
08/12/2010US20100204173 Methods of treating hepatic encephalopathy
08/12/2010US20100204172 Inactivators of o6-alkylguanine-dna alkyltransferase
08/12/2010US20100204171 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
08/12/2010US20100204170 Heterobifunctional pan-selectin inhibitors
08/12/2010US20100204169 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
08/12/2010US20100204167 Active compound combinations having insecticidal and acaricidal properties
08/12/2010US20100204166 Polyacetylenic compounds for stimulating insulin gene exression, production and secretion
08/12/2010US20100204165 Pesticidal Compositions
08/12/2010US20100204163 Metabolites and derivatives of ambrisentan
08/12/2010US20100204162 Substrate reduction therapy
08/12/2010US20100204161 Substances and Pharmaceutical Compositions for the Inhibition of Glyoxalases and Their Use Against Bacteria
08/12/2010US20100204146 Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
08/12/2010US20100204125 Genetic alterations associated with cancer
08/12/2010US20100204122 Treatment of osteoporosis in peri- and post- menopausal women with hepcidin
08/12/2010US20100204121 Dietary supplements containing terpenoid acids of maslinic acid or oleanolic acid and process for enhancing muscle mass in mammals
08/12/2010US20100204119 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5h)-yl phenyl derivatives
08/12/2010US20100204104 Fusion proteins containing two tgf-beta binding domains of tgf-beta type ii receptor
08/12/2010US20100204093 Use of heat shock activators for tissue regeneration
08/12/2010US20100204089 Phosphorylated pyrone analogs and methods
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203176 Method for reducing weight in a subject
08/12/2010US20100203175 DEGLYCATION OF AGEs
08/12/2010US20100203168 Use of calcitonin, SERMs such as raloxifene, testosterone, estrogen, calcimimetics such as cinacalcet, RANKL inhibitors such as denosumab, and bisphosphonates such as risedronate
08/12/2010US20100203166 Methods of preventing respiratory infections
08/12/2010US20100203164 Therapeutic Treatment of Cancer and Dysplasia of the Cervix or Vagina Using Estrogen Antagonists
08/12/2010US20100203163 Injectable polymer-lipid blend for localized drug delivery
08/12/2010US20100203162 Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
08/12/2010US20100203159 Metal component absorption enhancer in plant
08/12/2010US20100203153 Sustained-release nanoparticle compositions and methods using the same
08/12/2010US20100203151 Microspheres having core/shell structure
08/12/2010US20100203150 Novel amphiphilic copolymers and fabrication method thereof
08/12/2010US20100203148 Encapsulation and Controlled Release of Small Molecules for Intracellular Delivery Using Thermally Responsive Nanocapsules
08/12/2010US20100203147 Viruses for the Treatment of Cellular Proliferative Disorders
08/12/2010US20100203146 Intermittent dosing strategy for treating rheumatoid arthritis
08/12/2010US20100203145 Continuous process for microspheres production by using expanded fluids
08/12/2010US20100203142 Amphiphilic compound assisted nanoparticles for targeted delivery
08/12/2010US20100203140 Methods, compositions, and kits for organ protection during systemic anticancer therapy
08/12/2010US20100203134 Spheroids and multiparticulate tablets comprising them
08/12/2010US20100203133 High drug load tablet
08/12/2010US20100203132 Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and AT1 Receptor Antagonists
08/12/2010US20100203131 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
08/12/2010US20100203130 Pharmaceutical compositions resistant to abuse
08/12/2010US20100203129 Controlled release formulations with continuous efficacy
08/12/2010US20100203128 Bupropion hydrobromide and therapeutic applications
08/12/2010US20100203127 Large dose ribavirin formulations
08/12/2010US20100203126 Multilayered vitamin complex tablet containing ubidecarenone
08/12/2010US20100203123 Methods for improving cognitive function and decreasing heart rate
08/12/2010US20100203122 Delivery System for Remote Treatment of an Animal
08/12/2010US20100203119 Pharmaceutical treatment process using chitosan or derivative thereof
08/12/2010US20100203116 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
08/12/2010US20100203115 Organic-inorganic hybrid material for the storage and release of active principles
08/12/2010US20100203114 Micelle encapsulation of therapeutic agents
08/12/2010US20100203113 Wnt signalling inhibitors, and methods for making and using them
08/12/2010US20100203112 Composition of cationic phospholipid nanoparticles for effective delivery of nucleic acids
08/12/2010US20100203111 G-substrate for the treatment and prevention of parkinson's disease
08/12/2010US20100203110 Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production
08/12/2010US20100203107 Methods of Administering a Dermatological Agent to a Subject
08/12/2010US20100203105 Method for administering insulin to the buccal region
08/12/2010US20100203104 Delivery system for risperidone
08/12/2010US20100203103 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
08/12/2010US20100203102 Compositions and methods for treating post-operative pain using bupivacaine and an anti-onflammatory agent
08/12/2010US20100203100 Antimicrobial accessory for an implantable medical device
08/12/2010US20100203090 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
08/12/2010US20100203084 Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivator
08/12/2010US20100203083 Mutated structural protein of a parvovirus
08/12/2010US20100203079 Ophthalmic composition containing xanthan gum and amino acid
08/12/2010US20100203074 Compositions and methods for treating intracellular diseases
08/12/2010US20100203066 Polymeric linkers containing pyridyl disulfide moieties
08/12/2010US20100203065 Human liver regeneration associated protein and the use thereof
08/12/2010US20100203064 Methods and compositions for modulating wound repair
08/12/2010US20100203063 Pestivirus species
08/12/2010US20100203062 Methods and Compositions for Treatment of Neovascularization
08/12/2010US20100203061 Prevention and treatment of retinal ischemia and edema
08/12/2010US20100203060 Inhibitors for growth hormone and related hormones, and methods of use thereof
08/12/2010US20100203055 Hair regrowth promoter
08/12/2010US20100203053 Method and composition for treating immune complex associated disorders
08/12/2010US20100203051 Diagnostic markers for ankylosing spondylitis and uses thereof
08/12/2010US20100203043 Treatment and diagnosis of metastatic prostate cancer with inhibitors of epidermal growth factor receptor (egfr)
08/12/2010US20100203040 Genetic Products Which are Differentially Expressed in Tumors and Use Thereof
1 ... 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 ... 7860